World Journal of Gastroenterology

Article	Citations
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted	283
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	269
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China	221
Liquid biopsy for gastric cancer: Techniques, applications, and future directions	180
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	159
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	134
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	119
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	116
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	101
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	100
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	98
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	94
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	94
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	85
Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer	84
Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer	80
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	79
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	79
Intestinal flora was associated with occurrence risk of chronic non-communicable diseases	78
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	73
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	73
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	69
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome	67
Prognostic impact and reasons for variability by tumor location in gastric cancer	66
Modern drug discovery for inflammatory bowel disease: The role of computational methods	65

Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	63
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease	63
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	61
Management of Flood syndrome: What can we do better?	59
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	57
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer	56
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	56
Abdominal cocoon in children: A case report and review of literature	56
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	54
Examining dietary interventions in Crohn’s disease	54
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study	53
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	52
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism	52
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells	52
Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism	51
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management	50
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity	49
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	49
Systemic treatment for metastatic colorectal cancer	49
New objective scoring system to clinically assess fecal incontinence	48
Factors other than fibrosis that increase measured shear wave velocity	48
Nonlinear association between estimated plasma volume status and acute kidney injury in acute pancreatitis patients	47
Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy	47
New treatment for gastroesophageal reflux disease: Traditional medicine, Xiaochaihu decoction	46
Validation of prognostic scores for predicting acute liver failure and in-hospital death in patients with dengue-induced severe hepatitis	46
Increased systemic RNA oxidative damage and diagnostic value of RNA oxidative metabolites during Shigella flexneri-induced intestinal infection	45
Primary hyperparathyroidism-induced acute pancreatitis in pregnancy: A systematic review with a diagnostic-treatment algorithm	45
Parasites of the liver: A global problem?	45
Liver parasites: A global endemic and journey from infestation to intervention	45
Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives	44
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis	44
Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study	44
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication	44
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study	44
Endoscopic management of difficult common bile duct stones: Where are we now? A comprehensive review	43
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis	43
Artificial intelligence and inflammatory bowel disease: Where are we going?	43
Autoimmune liver diseases in systemic rheumatic diseases	43
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease	43
Updates in diagnosis and management of pancreatic cysts	42
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma	42
Artificial intelligence system for the detection of Barrett’s esophagus	42
Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success	42
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists	41
Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases	41
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship	40
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine	40
Advances and challenges in peroral endoscopic myotomy: Safety, precision, and post-procedure management	40
Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis	40
Timing of biliary decompression for acute cholangitis	40

Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China	39
Hepatitis B virus infection in patients with Wilson disease: A large retrospective study	39
Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives	39
Hepatitis B and circadian rhythm of the liver	39
Prediction of moderately severe and severe acute pancreatitis in pregnancy: Several issues	39
Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer	39
Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis	38
Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome	38
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination	38
Unveiling the anticancer effect of traditional Chinese herbal medicine	37
Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication?	37
Treatment of Helicobacter pylori infection in the presence of penicillin allergy	37
Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation	37
Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update	36
Secular decreasing trends in gastric cancer incidence in Taiwan: A population-based cancer registry study	36
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease	35
Orosomucoid in liver diseases	35
Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?	34
Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1	34
Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus	34
Epidemiology of small intestinal bacterial overgrowth	34
Current approaches to the management of jejunal variceal bleeding at the site of hepaticojejunostomy after pancreaticoduodenectomy	33
Depression weights in patients with gastric cancer: Bibliometric analysis as a weapon to chart the future of research	33
Esophageal melanosis: Two case reports and review of literature	33
Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications	33
Ras-related protein Rab24 plays a predictive role in hepatocellular carcinoma and enhanced tumor proliferation	33
Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans	32
18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3	32
Survival benefit of younger gastric cancer patients in China and the United States: A comparative study	32
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer	32
Development and validation of a predictive model for the pathological upgrading of gastric low-grade intraepithelial neoplasia	32
Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy	32
Artificial intelligence in colonoscopy	32
Correction to "CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma"	31
Real-time continuous image guidance for endoscopic retrograde cholangiopancreatography based on 3D/2D registration and respiratory compensation	31
Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer	31
High incidence combination of multiple primary malignant tumors of the digestive system	31
Photo-activated microtubule targeting drugs: Advancing therapies for colorectal cancer	31
Anti-RPL30 as a novel biomarker for enhanced diagnosis of autoantibody-negative primary biliary cholangitis	31
Bibliometrics analysis based on the Web of Science: Current trends and perspective of gastric organoid during 2010-2023	31
Distinct gut microbiomes in Thai patients with colorectal polyps	31
Lipocalin-2 and intestinal diseases	30
Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer	30
Comprehensive approach to esophageal variceal bleeding: From prevention to treatment	30
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients	30
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives	30
Artificial intelligence for hepatitis evaluation	29
Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs	29
Pediatric stricturing Crohn's disease	29
Gut microbiota and female health	29
Prognostic role of intestinal ultrasound in Crohn’s disease	29
Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital	29
Role of albumin-bilirubin score in non-malignant liver disease	29
Liver biopsy in the post-hepatitis C virus era in Japan	28
HP0953 hypothetical protein overexpresses and localization as virulence factor from Helicobacter pylori during infection to gastric epithelium cells	28
Revaluation of Helicobacter pylori's role in esophageal carcinoma: A call for comprehensive research	28
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease	28
Environmental perspectives of COVID-19 outbreaks: A review	28
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan	27
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment	27
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era	27
Gut microbiota plays a key role in the development of colorectal cancer	27
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor	27
Intracellular alpha-fetoprotein mitigates hepatocyte apoptosis and necroptosis by inhibiting endoplasmic reticulum stress	27
Chinese patent medicine: Opening new perspectives for treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients	27
Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease	27
Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score	26
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison	26
Link between childhood obesity and gut microbiota	26
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	26
Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer	26
Important role of lymphovascular and perineural invasion in prognosis of colorectal cancer patients with N1c disease	26
Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells	26
Triglyceride-glucose index as a prognostic indicator in advanced gastric cancer: Insights and future research	26
Unraveling the therapeutic potential of Calculus Bovis in liver cancer: A novel step for targeted cancer treatment	26
Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments	25
Ligation-assisted endoscopic submucosal resection following unroofing technique for small esophageal subepithelial lesions originating from the muscularis propria	25
Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics	25
Prevalence and clinical impact of sarcopenia in liver transplant recipients: A meta-analysis	25
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases	25

Current status and progress in laparoscopic surgery for gallbladder carcinoma	24
Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer	24
Hepatic perivascular epithelioid cell tumor: Clinicopathological analysis of 26 cases with emphasis on disease management and prognosis	24
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review	24
Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma	24
Idiopathic retroperitoneal fibrosis arising from peritoneal space: A case report and review of literature	24
Diagnostic tools for fecal incontinence: Scoring systems are the crucial first step	24
Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases	24
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases	24
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy	24
Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication	23
Interaction between diet and genetics in patients with inflammatory bowel disease	23
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis	23
Optimal timing of biliary drainage based on the severity of acute cholangitis: A single-center retrospective cohort study	23
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?	23
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease	23
Challenges involved in the application of artificial intelligence in gastroenterology: The race is on!	23
Transanal eco-Doppler evaluation after hemorrhoidal artery embolization	23
Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma	23
Close relationship between mediators of inflammation and pancreatic cancer: Our experience	23
Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo	23
Radiomics for the detection of microvascular invasion in hepatocellular carcinoma	22
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions	22
Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”	22
Exploring non-curative endoscopic submucosal dissection: Current treatment optimization and future indication expansion	22
Abnormally activated wingless/integrated signaling modulates tumor-associated macrophage polarization and potentially promotes hepatocarcinoma cell growth	22
Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system	22
Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number	22
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis	22
Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis	22
Unlocking the potential of Calculus bovis: A breakthrough in liver cancer treatment via Wnt/β-catenin pathway modulation	22
Locked nucleic acid real-time polymerase chain reaction method identifying two polymorphisms of hepatitis B virus genotype C2 infections, rt269L and rt269I	22
Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma	22
Anabolic androgenic steroid-induced liver injury: An update	22
Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease	22
Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it	22
Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats	22
Gastric cancer incidence based on endoscopic Kyoto classification of gastritis	22
Multi-clustering study on the association between human leukocyte antigen-DP-DQ and hepatitis B virus-related hepatocellular carcinoma and cirrhosis in Viet Nam	21
N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression	21
Paneth cells inhibit intestinal stem cell proliferation through the bone morphogenic protein 7 pathway under rotavirus-mediated intestinal injury	21
Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study	21
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China	21
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury	21
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease	21
Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinoma	21
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study	21
Sequence of events leading to primary biliary cholangitis	21
Guidelines on postoperative magnetic resonance imaging in patients operated for cryptoglandular anal fistula: Experience from 2404 scans	21
Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome	21
Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer malignant behaviors by activation of target of rapamycin kinase/autophagy signaling	21
Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer	21
Genetic intersection of human leukocyte antigen-DP/DQ and hepatitis B virus-related liver disease: Insights from a multi-clustering study	21
Linear endoscopic ultrasound: Current uses and future perspectives in mediastinal examination	21
Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer	21
Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells’ T helper 17 polarization	21
Application of Wuling powder in the treatment of ulcerative colitis complicated by depression as a new therapy principle	21
Computed tomography-based radiomics combined with machine learning allows differentiation between primary intestinal lymphoma and Crohn's disease	20
Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis	20
Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?	20
Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study	20
Syngeneic implantation of mouse hepatic progenitor cell-derived three-dimensional liver tissue with dense collagen fibrils	20
Long noncoding RNA TNFRSF10A-AS1 promotes colorectal cancer through upregulation of HuR	20
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?	20
Hepatic arterial infusion chemotherapy with anti-angiogenesis agents and immune checkpoint inhibitiors for unresectable hepatocellular carcinoma and meta-analysis	20
F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit	20
Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”	20
Brown slits for colorectal adenoma crypts on conventional magnifying endoscopy with narrow band imaging using the X1 system	20
Advances in understanding and managing celiac disease: Pathophysiology and treatment strategies	20
Gut microbiota predicts the diagnosis of celiac disease in Saudi children	20
Trichostatin A augments cell migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma through BRD4/c-Myc endoplasmic reticulum-stress pathway	20
Successful treatment of an enormous rectal mucosa-associated lymphoid tissue lymphoma by endoscopic full-thickness resection: A case report	20
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease	20
Mechanisms of ductular reaction in non-alcoholic steatohepatitis	20
New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy	20
Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients	19
Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study	19
Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet	19
Insights into induction of the immune response by the hepatitis B vaccine	19
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities	19
Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era	19
MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?	19
Protective effects of autologous bone marrow-derived mesenchymal stem cell transplantation on acute radioactive enteritis in Beagle dogs	19
Long COVID and gut candidiasis: What is the existing relationship?	19
Age-specific causes of upper gastrointestinal bleeding in children	19
Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases	19
Mean nocturnal baseline impedance in gastro-esophageal reflux disease diagnosis: Should we strictly follow the Lyon 2 Consensus?	19
Is Helicobacter pylori infection protective against esophageal cancer?	19
Percutaneous transhepatic cholangiography vs endoscopic ultrasound-guided biliary drainage: A systematic review	19
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring	19
Endoscopic treatment of scarred polyps with a non-thermal device (Endorotor): A review of the literature‎	19
Hepatocellular adenoma: Where are we now?	18
Role of magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori infection and gastric precancerous conditions: Few issues	18
Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis	18
Reactive oxygen species and oxidative stress in acute pancreatitis: Pathogenesis and new therapeutic interventions	18